Sign in

ICU MEDICAL INC/DE (ICUI)

Q1 2025 Earnings Summary

Reported on May 8, 2025 (After Market Close)
Pre-Earnings Price$142.87Last close (May 8, 2025)
Post-Earnings Price$135.35Open (May 9, 2025)
Price Change
$-7.52(-5.26%)
MetricYoY ChangeReason

Total Revenue

+6.7% (from $566.655M to $604.702M)

The increase is attributed to sustained market demand and improved pricing strategies, driving revenue growth from $566.655M in Q1 2024 to $604.702M in Q1 2025.

Operating Income

Reversed from a loss of $10.655M to a profit of $12.888M

The turnaround in operating income is driven by better operating efficiencies, cost control, and an improved product mix that helped transform a loss into profitability.

Gross Profit

+13.4% (from $185.244M to $210.109M)

The gross profit improvement reflects enhanced production margins and effective cost management measures, increasing from $185.244M in Q1 2024 to $210.109M in Q1 2025.

Net Loss

Reduced by 60% (from $39.471M to $15.476M)

The significant narrowing of the net loss is driven by operational leverage gains and margin improvements, decreasing the loss from $39.471M to $15.476M, indicating focused cost and efficiency measures.

MetricPeriodGuidanceActualPerformance
Revenue YoY
Q1 2025
Low- to mid-single-digit growth range
6.7% YoY growth (from 566.655MTo 604.702M)
Beat

Research analysts covering ICU MEDICAL INC/DE.